Bolt Biotherapeutics, Inc. (BOLT) vs Exicure, Inc. (XCUR)
A side-by-side comparison of Bolt Biotherapeutics, Inc. and Exicure, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BOLT
Bolt Biotherapeutics, Inc.
$3.51HealthcareDelayed quote: Oct 6, 2026, 3:59 PM EDT
XCUR
Exicure, Inc.
$1.08HealthcareDelayed quote: Oct 6, 2026, 3:59 PM EDT
Total return — BOLT vs XCUR
growth of $100 · dividends reinvested · last 6yBOLT -99.5% (-58.1%/yr)XCUR -99.7% (-61.8%/yr)BOLT compounded faster over this window
BOLT XCUR
BOLT vs XCUR: by the numbers
- •XCUR is the larger company ($7M vs $7M market cap).
- •Both run net losses; XCUR's is the smaller (0.00% vs -611.47% net margin).
Metrics side by side
Valuation
| Metric | BOLT | XCUR |
|---|---|---|
| P/S ratio | 1.44 | N/A |
| P/B ratio | 0.53 | 7.05 |
Profitability
| Metric | BOLT | XCUR |
|---|---|---|
| Gross margin | 80.62% | 0.00% |
| Operating margin | -450.07% | 0.00% |
| Net margin | -611.47% | 0.00% |
| ROE | -227.37% | -847.90% |
| ROIC | -90.17% | -101.07% |
Growth (annualized)
| Metric | BOLT | XCUR |
|---|---|---|
| Total return CAGR (5Y) | -57.61% | -64.13% |
Frequently asked
- How have BOLT and XCUR total returns compared?
- Over the past 5 years, BOLT delivered -57.61% and XCUR delivered -64.13% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.